Innovative Approaches
Geron is built on a foundation of scientific innovation. We are developing novel therapeutics using innovative technologies and unique approaches that we believe could meaningfully address the unmet medical needs of patients with cancer. The approaches are being evaluated in clinical trials today and include:
- Inhibiting telomerase, a key molecular hallmark of cancer, using proprietary nucleic acid chemistry
